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We have postulated that the donor leukocyte micro-
chimerism plays a seminal role in the acceptance of 
allografts by inducing and perpetuating variable de-
gree of donor-specific nonreactivity in long-surviving 
organ recipients. Limited information is available, 
however, concerning the phenotype and function of 
these chimeric cells in humans. The unequivocal pres-
ence of donor dendritic cells (DCs), a prominent lin-
eage in the microchimerism observed in rodents and 
clinical organ recipients, was difficult to demonstrate 
in bone marrow (BM)-augmented organ transplant re-
cipients. This enigma was resolved by the recent de-
scription of a method for propagating circulating hu-
man DCs from their progenitors by culture in a 
medium enriched with granulocyte-macrophage colo-
ny-stimulating factor and interleukin 4, a condition 
known to inhibit outgrowth of monocytes, thus pro-
viding a selective growth advantage to committed pro-
genitors of the myeloid lineage. Cells from BM-aug-
men ted organ recipients and normal control subjects 
harvested from 12- to 14-day cultures exhibited den-
dritic morphology and potent allostimulatory capac-
ity. Using appropriate primers, the presence of donor 
DNA was verified by polymerase chain reaction within 
the lineageDull/class IIbril{ht sorted DC. Phenotypic 
analysis of cultured DCs from BM-augmented pa-
tients, unlike that of controls, exhibited a marked 
down-regulation of B7-1 (CD80) while retaining nor-
mal levels of expression of B7-2 (CD86) cell surface 
molecules. The presence of donor DNA was also con-
firmed by polymerase chain reaction in individually 
sorted lineage + (T. B, and NK) cells and macrophages, 
suggesting that the chimerism in BM-augmented pa-
tients is multilineage. The presence of progenitors of 
donor DCs in the peripheral blood of BM-augmented 
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patients further substantiates the already convincing 
evidence of stem cell engraftment. 
The diffuse migration of passenger leukocytes from trans-
planted organs into the recipient has been proposed as the 
first step toward allograft acceptance and the induction of 
variable degrees of donor-specific tolerance (1-4). In this 
paradigm, acceptance of various organs hinges on the quan-
tity and quality of tolerogenic resident migratory cells with a 
critical role for cells of the dendritic leukocyte lineage (5-11) 
first characterized by Steinman and Cohn (12,13). Although 
dendritic cells (DCs*) and their progenitors have been iso-
lated from various mouse (14-18) and rat (19) tissues, such 
studies were not possible in humans until Romani et al. (20) 
described a modified culture technique for propagation of 
DCs from their progenitors in human blood. We argue that 
demonstration of these progenitors in the presence of other 
lineages in peripheral blood mononuclear cells (PBMCs) 
would provide strong evidence for engraftment of stem cells 
in organ recipients given adjunct bone marrow (BM) infusion 
(21). Added to previous observations in rodents (22-26), such 
findings would explain the long-term perpetuation of multi-
lineage donor cell chimerism in all successful organ allograft 
recipients decades after transplantation (3, 4). 
Here, we present evidence that chimerism in BM-aug-
mented organ transplant human recipients is indeed multi-
lineage. Culture of their peripheral blood in recombinant 
human granulocyte-macrophage colony-stimulating factor 
(rhGM-CSF)- and interleukin 4 (rhIL-4)-enriched medium 
resulted in propagation of progenitors of DCs, which were 
confirmed to be those of donor origin. The functional signifi-
cance ofthis finding and its role in the induction of tolerance, 
however, remains to be clarified. 
l\IATERlALS AND METHODS 
lsolatwn ot" PBMes. Peripheral blood (40 ml) was obtained from 
six patients who had previously received an ABO-compatible but 
HLA-mismatched organ diver. n =4: heart. n= 1: kidney, n = 1) trans-
plant accompanied with perioperative augmentation of chimensm 
with 3-5x 10H unmodified BM cellslkg bodv weight (2]), The patients 
• Abbreviations: BM. bone marrow: DC. dendritic cell: EM. elec-
tron microscopy; FITC. J1uorescein isothiocyanate; mAb. monoclonal 
antibody; MLR. mixed leukocyte reaction; NK. natural killer; PBMC. 
peripheral blood mononuclear cell; peR. polymerase chain reactIOn; 
PE. phycoerythrin; rhGM-CSF. recombinant human granulocyte 
macrophage-colony stimulating factor; rhIL-4. recombinant human 
interleukin 4: SRY. sex-determming regIon of the Y chromosome. 
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(CD45 +/CD14', Becton Dickinson!. The variable degree ofCD45 and 
CD14 staining also allowed for delineation of lymphocytes. mono-
cytes, and granulocytes present in the peripheral blood of the recl p_ 
ients. The use of the latter technique provided an additional means 
for confirming the presence of cells of multilineage origin within the 
donor-specific class II + population. Unstained cells and cells stained 
with appropriate fluorochrome-conjugated, isotype-matched irrele-
yant mAb were used as negative controls. For analysis, 5 X 104 events 
were acquired with wide gates. as well as with gates encompassing 
the lymphocyte or monocyte populations. As with DCs, the presence 
of donor cells within the sorted lineage r cells was determined by 
PCR analysis. 
Sept. 
were not preconditioned with any cytoablative or cytoreductive reg-
imens. and after transplantation they were maintained on routine 
daily immunosuppression with tacrolimus and steroids. Blood ob-
tained from normal. healthy human volunteers served as controls for 
propagation of DCs in culture and for in vitro proliferative assays. 
PBMCs were isolated by centrifugation of peripheral blood on a ficoll 
gradient (density = 1.077) for 30 min at 160 X g at room tempera-
ture. After lysis of erythrocytes with red cell lysing buffer (Sigma 
Chemical Co .. St. Louis. MOl, the cells were washed twice with RPMI 
and counted. Viability was determined by trypan blue dye exclusion 
technique. 
Culture medium. AIM-V serum-free lymphocyte medium (Life 
Technologies, Gaithersburg, Mm, containing L-glutamine (2 mM), 
streptomycin sulfate (50 "g/ml- i ), and gentamicin sulfate (10 "g/ 
ml- 1) was used in all cultures. For the selective propagation of 
progenitors of myeloid lineage, the culture medium was supple-
mented with rhGM-CSF (103 U/ml- i ) and rhIL-4 (l03 U/ml- i ), 
which were generously provided by Schering-Plough (Kenilworth, 
NJ1. 
Culture of PBMCs in cytokine-rich medium. The method was sim-
ilar to that of Romani et a1. (20). PBMCs obtained from organ 
transplant recipients were resuspended in culture medium (without 
cytokine supplementation) and plated at a concentration of 106 cells/ 
well- 1 in 6-well plates (Coming, Inc., Coming, NY) for 2 hours at 
37°C in 5% CO2 in air. At the end ofthis incubation, the nonadherent 
cells were gently removed, and the wells (containing the adherent 
population) were washed twice with warm (37°C) medium; caution 
was exercised not to dislodge adherent and loosely adherent cells. 
Fresh cytokine-rich medium was then added to each well, and the 
cells were allowed to proliferate. Every 72-96 hr until harvest the 
plates were gently swirled, and one half of the culture medium was 
aspirated and replenished with an equivalent volume of fresh cyto-
kine-supplemented medium. After 12-14 days of culture, the spon-
taneously released cells were harvested, and the DCs were further 
purified by flotation on metrizamide columns (Life Technologies) as 
described by Freudenthal and Steinman (27). 
Sorting of DCs. To further enrich for DCs, we sorted the cells 
contained within the low-density fraction at 4°C. For sorting, 106 
cells were aliquoted into each of 96 wells of a U-bottomed plate 
(Coming) and centrifuged at 160 x g for 3 minutes. To block non-
specific binding, cells were incubated with 10% heat-inactivated goat 
serum for 15 min and washed twice with washing solution (phos-
phate-buffered solution. 5% fetal calf serum. and 0.01'70 NaN,). The 
cells were subsequently incubated for an additional 30 min with a 
cocktail of phycoerythrin (PEl-conjugated lineage-specific monoclo-
nal antibodies (mAb; purchased from Becton Dickinson, Mountain 
View. CAl directed against T (CD3+), B (CD22+), and NK (CD56+) 
cells and macrophages (CD14 +), and fluorescein isothiocyanate 
(FITC1-conjugated mAb against HLA-DR. Using an Epics Elite flow 
cytometer (Coulter Corp., Hialeah. FLl equipped with an air-cooled 
argon laser. lineageUullfHLA class II+ cells were sorted; both pheno-
typic and light scatter characteristics were used for the identification 
of various subpopulations. The sorted population (10 j cells/sec 1) 
was reanalyzed for the determination of their purity. Unstained cells 
and cells stained with appropriate fluorochrome-conjugated. isotype-
matched irreleyant mAb were used as negative controls. The pres-
ence of donor cells within the sorted population was subsequently 
examined by polymerase chain reaction (PCR) analysis. Addition-
ally. puritied sorted DCs were also processed for elaboration of their 
ultrastructure by electron microscopy (EM) and for phenotyping (see 
below!. 
DetectIOn o( mullllineage chimerzsm. The PBMCs of the recipi-
ents. stained with yarlOUS lineage-specitic (CD3. CD14. CD22. ;.llld 
CD56) mAbs {Bl'cton Dickinson!. were sorted and reanalyzed for 
punty using Epics Elite t10w cytometer {Coulter!. For the purpose of 
this sort mg. an analysis gate was established using the forward and 
.,rthogonaJ light scatter protiies ofunstamed cells. ieukoc~Dte subsets 
\\"f're determmed both bv the use of light scatter as well as Leucogate 
Fluorocytometric analysis of cultured I sorted DCs. The cell sur-
face phenotype of the cultured DC was determined by staining with 
FITC-Iabeled anti-HLA-DR and a cocktail of lineage (anti-CD31 
CDl41CD221CD56)-specific mAbs. Additionally, expression of COla 
(M-T102), CD80 CB7.1; BBl), and CD86 (B7.2; IT2.2) was also deter-
mined on cultured HLA_DRbrightllineageDuII_sorted cells using mAbs 
obtained from PharMingen (San Diego, CAl. 
PCR. The presence of donor DNA was detected in the unsorted 
and sorted cells of the recipients by a procedure described previously 
(3,21,28). Using oligonucleotide primers specific for the sex-deter-
mining region of the Y (SRY) chromosome (in male-female trans-
plant recipients) or for the appropriate mismatched HLA class II 
allele, the DNA was amplified by PCR and resolved by electrophore-
sis on an agarose gel. After Southern blotting, the membranes were 
hybridized with an allele-specific radiolabeled probe, washed, ex-
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FIGURE 1. Sorting for HLA_DRbnght/lineage"UIl cells using cultured 
metrizamide-fractionated putative DC generated using PBMCs ob-
tained from a male-female kidney + 8M recipIent 345 days after 
transplantation. The sorting gates te) were set lor HLA_DRbnght hut 
lineage"Ull population. and subsequent to low-speed sorting. the cells 
were reanalyzed for purity {Dl. Only cells exhibiting -100% purity 
were used for EM studies and for phenotyping. The presence of donor 
DNA was contirmed by PCR analysis IDl using primers specific for 
SRY. For flow cvtometric analYsis-. unstained and cells stained with 
t1uorochrome-c~ngrgated irreievant isotype-matched mAbs were 
used as controls. PBMCs obtained from normal healthy males and 
females served as positiYe and negative controls. respectivelY. for 
PCR analysis. PGE. percentage gated eyents: SSC. side scatter chan-
nel: FSC. forward scatter channel. 
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FIGURE 2. Determination of expression of costimulatory molecules on cultured/sorted. DC generated from the PBMCs obtained from a liver + BM 
recipient 467 days after transplantation. Spontaneously released cells cultured in rhGM-CSF - and rhfi-4~mriched medium were purified further 
by flotation on metrizamide columns. The harvested low-density cells were stained with a cocktail of PE-conjugated lineage-specific (CD3ICDl41 
CD221CD56l and FITC-conjugated anti-lll..A-DR mAb. LineagenulllHLA class IIbright cells were sorted. (Cl using an Epics Elite flow cytometer 
(Coulter) and reanalyzed (0) to determine their purity. Sorted. cells were then subjected to staining with PE-conjugated mAbs against CD80 (B7.1; 
El, CD86 (B7.2; Fl, and CDla (G). Unstained cells and cells stained with fluorochrome-conjugated irrelevant isotype-matched mAbs were used as 
controls. SSC, side scatter channel; FSC, forward scatter channel; PGE, percentage gated events. 
posed to an autoradiograph, and developed. This technique allowed 
for a detection sensitivity of one donor cell per 106 _106 recipient cells. 
For detection of Y chromosome. PBMCs obtained from normal male 
and female individuals were used as positive and negative controls, 
respectively. Additionally, for the identification of heterotopic 
HLA-DR alleles. cells from normal matched and unmatched volun-
teers were used as positive and negative controls, respectively. 
Mixed leukocyte reaction (MLRJ. To ascertain the allostimulatory 
capacity of cultured DCs. primary MLR assays were performed. A 
constant number of autologous responders ( 106 PBMCs or purified T 
cells per well-I) and responders obtained from HLA mismatched 
healthy human volunteers were cultured with increasing concentra-
tions of y-irradiated stimulators (purified DCs, PBMCs, or spleno-
cytes) in a 96-well U-bottomed microtiter plate (Coming) for 6 days 
in 5% CO2 , One day before harvesting, each well was pulsed with 1 
/-LCi of [JH1thymidine INEN. Boston, MA), and the cells were har-
vested (Skatron, LKB. Wallac, Gaithersburg, MOl onto glass fiber 
filter mats (Wallac Oy, Turka. Finland). with incorporation of radio-
activity determined by liquid scintillation counting (Betaplate 1205, 
Pharmacia LKB. Gaithersburg, MOl. The results are expressed as 
the mean I"Hlthymidine incorporation in tnplicate cultures. 
Electron microscopy (EM) of'sorted Des. To further confirm the 
identity of DCs, their distinct ultrastructure was determined with 
EM. For this purpose. cultured sorted DCs were centrifuged (160 x 
gl and lixed as a pellet in 2.5',"0 glutaraldehyde (Sigma Chemical Co.l 
in phosphate-butTered saline (pH 7.2l. After tixation, the pellet was 
incised into small (i-mm) cubes and posttixed for 60 min in osmium 
tetroxide. At the end of this treatment. the cubes were dehydrated by 
passage through graded series of alcohols before being embedded in 
Spon (Energy Beam Sciences. Agawam. :-OrA). Ultrathin (60-nm) 
,;ections obtained using Leica Ultracut S mIcrotome I Leiea. Dear-
born. lIIIl were counterstained in 2'''r uranvl acetate for 7 min and lex 
iC:1d citrate for 2 min. Cltrastructure was examined using a JEOL 
1:!10 (Peabodv. lI.rA) transmiSSIOn electron microscope. 
RESULTS 
Culture of DCs. After 3-4 days of culture in cytokine-
supplemented medium, PBMes from the BM-augmented re-
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FIGURE 3. A1lostimulatory capacity of y-irradiated cultured DC was 
determined using a primary MLR assay. For the method used to 
generate DC. refer to legend of Figure 1. PBMCs were obtained from 
two liver + BM recipients 781 days (A) and 467 days IE) after 
transplantation. A constant number (106 cells/well) of autologous IQ) 
and allogeneIc (0) PBMCs and allogeneic purified naive T cells I.) 
were used as responders. In addition to cultured DC (1), splenocytes 
obtained from the cadaveric donor (2) and the PBMCs of recipients 
I :3) were also used as stimulators. The results are expressed as the 
mean I"Hlthynudine incorporation in triplicate cultures. 
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FIGURE 4. Analysis of the ultrastructure of the cultured/sorted (lin-
eagenulllHLA class nbright) DC obtained from the PBMCs of a BM-
augmented liver allograft recipient 390 days after transplantation. 
All cells examined exhibited typical "organelle-deficient" cytoplasmic 
veils (arrow) with sparse secretory granules. The mitochondrial con-
tent varied between cells; some had low (Al but others very high (B) 
numbers. As is evident, the cytoplasmic development was also highly 
variable in the cells examined. mtrastructure was determined using 
a JEOL 1210 (Peabody, MAl transmission electron microscope (mag-
nification, X4500). 
cipients and from healthy human volunteers contained 
loosely adherent cells that exhibited typical dendritic mor-
phology. Further incubation resulted in eventual prolifera-
tion of adherent aggregates, which over the next 7-10 days 
released typical "veiled" DCs. 
Further purification of Des. For determination of donor 
DNA (by PCR), phenotyping, and for EM analysis of the 
ultrastructure of the putative DC, cultured, metrizamide 
fractionated DCs were further purified by sorting. HLA-
DRbrightllineagenUll(CD3ICD221CD56/CDI4) cells were gated 
(Fig. lC) and subjected to deliberate low-rate (103 cells/sec-I) 
sorting. Subsequent to sorting, the cells were reanalyzed to 
confirm their purity (Fig. ID). Only cells with 100% purity 
were used for subsequent analysis. 
Phenotyping of cultured / sorted Des. The low-density frac-
tions of DCs purified on metrizamide columns were har-
vested and analyzed using immunofluorescent staining. Flow 
cytometric analysis of stained cells revealed marked 
HLA-DR but little or no expression of markers for T (CD3+), 
B (CD22+), NK(CD56+), cells and macrophages lCD14 +; Fig. 
2C). Within the cultured/sorted (lineagenull/class nbright) 
DCs. evidence for the levels of expression of costimulatory 
(CD80. CD8Sl molecules and of those thought to be necessary 
for antigen presentation (CDla) also was sought. The only 
discernible difference between the phenotype of DCs ob-
tained from various PBMC donors was the remarkedly down-
regulated cell surface expression of costimulatory molecule 
B7-1 (CD80l in BM-augmented patients (Fig. 2E) compared 
with that of healthy controls. In contrast. high levels of 
expression ofB7-2 (CD86: Fig. 2F) and that ofCDla (Fig. 2Gl 
were comparable in the study and control groups. 
Determination of allostimulatory capacity. The mature 
DCs present among the cells of spleens procured from the 
cadaveric donors of the BM-augmented organ recipients gen-
erated a moderate allostimulatory response when used as 
:;timulators against naive allogeneic T cells and/or allogeneic 
PBMC responders I Fig. 3>. Similar control studies using the 
PBMCs of the recipients as stimulators also showed modest 
allostimuiation I ci~K J). contirming the presence within this 
population ot' potent antigen-presenting- cells. The most strik-
ing observation was made when the cultured DCs ultimately 
purified on metrizamide columns were used as stimulators. 
Although autologous PBMCs were nonresponsive, allogeneic 
T cells and PBMCs when used as responders exhibited two-
to threefold higher proliferation than that after their expo-
sure to spleen and/or PBMC stimulators (Fig. 3). The aUo-
stimulatory capacity of cultured DCs obtained from all BM-
augmented patients, as well as healthy controls, was always 
at least 1-2 log higher than that of fresh splenocytes or 
PBMCs. A representative outcome in two BM-augmented 
recipients is shown in Figure 3. 
EM analysis of ultrastructure of Des. Highly purified 
sorted cells obtained from both study patients and normal 
healthy controls exhibited an ultrastructure characteristic of 
cells of dendritic leukocyte lineage (16, 20). There was an 
abundance of slender "organelle-deficient" cytoplasmic pro-
cesses (veils), sparse secretory granules, and scant rough 
endoplasmic reticulum (Fig. 4). Although the mitochondrial 
content varied between cells (Fig. 4A vs. 4B), the presence of 
characteristic "racket-shaped" Birbeck granules, known to be 
associated with endocytosis, could not be confirmed. The 
cytoplasmic development also was highly variable in the cells 
examined. 
peR detection of donor DNA in cultured/sorted Des. 
Using primers specific for either heterotypic HLA alleles or 
else the SRY region of the V-chromosome (in male-female 
recipients), the presence of donor DNA was detected by PCR 
in the cultured sorted DCs obtained from 4 of 5 (80%) BM-
augmented organ recipients 279-755 days after transplan-
tation (Table 1). Our inability to detect donor DNA in 1 of 5 
patients evaluated probably reflected technical limitations 
inherent with extraction of an insufficient amount of DNA for 
PCR analyses from a very low ( <4-5 X 102 ) number of sorted 
cells. An alternative explication might be that donor-specific 
DNA was not present in the DCs population sorted from this 
patient. 
Evidence for the presence of multilineage donor cell micro-
chimerism. The potential engraftment of pluripotent stem 
cells contained within the infused BM in augmented organ 
transplant recipients and the subsequent establishment of 
multilineage chimerism in their peripheral blood was con-
firmed by two mutually corroborative techniques. Using or-
thogonal and side scatter flow cytometric profiles, the pres-
ence of reciprocal concentrations of recipient and donor cells 
was evidenced in open (Fig. 5, la, C, and D) as well as 
lymphocyte (Fig. 5, IIb. C, and Dl- and monocyte (Fig. 5, IIIc, 
C, and D)-gated populations. This observation was further 
substantiated by the demonstration of the presence of donor 
DNA by PCR in the sorted T (CD3+; Fig. SE), B (CD22+; Fig. 
TABLE 1. Detection of donor DNA within the sorted Oineage"ull/ 
class IIbn"ht) putative DC obtained from rhIL-4 and rhGM-CSF-
enriched cultures of recipient PBMC 
Transplanted orJl"ans peR POD" Donor DNA within probe lineageUUll/class IIbnoh' cells 
Liver+BM DR14 755 ... 
Liver+BM SRY :348 .,. 
Liver+BM SRY 390 + 
Kidney.,. pancreas + 81\1 DR2 :!79 
Kidney - 81\1 SRY :145 
--------_._-----
, Postoperatlve dav on which blood sample was recovered. 
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FIGURE 5. Establishment of the multilineage nature of chimerism in the peripheral blood of a BM-augmented lung allograft recipient 475 
days after transplantation. The orthogonal and side scatter profiles were used to establish analysis gates for lymphocyte <In and monocyte 
mn subpopulations. Within this population. the presence of cells staining with either donor (D)- or recipient (C)-specific mAbs was 
determined. Unstained and cells stained with fluorochrome-conjugated. irrelevant, isotype-matched mAbs (B) were used as controls. SSC, 
side scatter channel; FSC. forward scatter channel; PGE. percentage gated events. 
6C). and NK (CD56+; Fig. 6D) cells and monocytesimacro-
phages (CD14 +; Fig. 6F) of the recipients. It is noteworthy 
that all evaluated patients exhibited evidence for the pres-
ence of T and B cells of donor origin within their peripheral 
blood, whereas the presence of NK cells and macro phages 
was highly variable (Table 2). 
DISCUSSION 
It was postulated after the discovery of microchimerism in 
the long-surviving human organ recipients that the donor-
derived leukocytes were muitilineage, that this outcome was 
no different in principle than what could be produced by a 
BM infusion to a noncytoablated recipient. and that persis-
tence of the chimeric cells was dependent on the engraftment 
of pluripotent stem cells (1. 3. 4), These conclusions have 
been verified in rodents (7-10.22). but the constituency ofthe 
chimerism is not known to have been studied in humans 
except in a preliminary communication \29) and in a manu-
script in press \30). In the studies reported herein. donor cells 
of various lineages (T. B. NK cells. macrophages. and DCs) 
were sorted from the peripheral blood of six BM-augmented 
organ allograft recipients who were at least 1 year after 
transplantation. The presence within the various sorted cells 
Ilf DNA of donor origin was contirmed by peR analysis. 
Our most difficult objective. and the most cruCial. was to 
establish the presence of circulating leukocytes of DC lineage 
in BM-augmented organ recipients. The role of DCs in initi-
ating primary immune responses has been well documented 
(31). As immature cells. DCs display avid phagocytic capacity 
but as a result of a lack of expression of appropriate costimu-
latory molecules. they cannot induce optimal proliferation of 
naive T cells (31). Subsequent to antigen uptake. DCs un-
dergo rapid transformation, which among other changes, in-
volves differential up-regulation of costimuiatory molecules, 
resulting in their acquisition of potent antigen-presenting 
capacity. There is considerable evidence that a majority of 
resident DCs within the nonlymphoid organs express the 
phenotype and function of immature cells (16. 32. 33). and 
that these cells mature and migrate to secondary lymphoid 
organs of the recipient after organ transplantation. initiating 
allograft rejection \34, 35). The latter observation has 
prompted strategies designed to either deplete (36. 37) or 
modify (38) the function of resident Des before organ trans-
plantation. This approach has resulted in moderate prolon-
gation of allograft survival but has failed to induce donor-
specific tolerance. 
We have reported previously that livers transplanted or-
thotopically across many MHC-disparate mouse strain com-
binations were accepted spontaneously with contemporane-
ous establishment of stable microchimerism and the 
induction of donor-specific tolerance \91. There is now grow-
i ng evidence that this outcome in mice hinges on the presence 
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FIGURE 6, The detection of donor DNA by peR in lineage-positive cells sorted from PBMCs obtained from a male-female liver + BM organ 
recipient 402 days after transplantation. Scatter profile was used to establish gates specific for the lymphoid (A) and myeloid eE) populations. 
Subsequently, the purity of sorted T (B), B (C), and NK (D) cells and monocyte/macrophages (F) was determined by reanalysis. Within the 
sorted population, the presence of donor DNA was confirmed by PCR analysis using primers specific for the SRY. For flow cytometry, 
unstained and cells stained with fluorochrome-conjugated, irrelevant, isotype-matched mAbs were used as controls. PBMCs obtained from 
normal males and females served as positive and negative controls, respectively, for PCR analysis. SSC, side scatter channel; FSC, forward 
scatter channel; PGE, percentage gated events. 
TABLE 2. Detection of donor DNA within lineage-sorted cells ob-
tained from bone marrow-augmented organ transplant recipientsa 
PCR detection of donor DNA 
Transplanted organs PCR within: probe 
CD3+ CD14+ CD22+ CD56+ 
Kidney+BM SRY NDb + + 
Heart+BM DR2 + + 
Liver+BM DR14 + 
Liver+BM SRY + + + + 
Liver+BM DR53 + 
Liver+BM SRY ND ND ... ND 
a Peripheral blood was obtained from patients who were at least 1 
year post-transplantation. 
h ND, not done; insufficient cell yield. 
within the liver of an optimal number of "immature" DCs, 
many of which migrate and provide tolerogenic rather than 
stimulatory signals to the naive T cells of the host (9, 16). 
This "diametrical" function of DCs has been implicated in the 
"veto" effect of donor leukocytes observed in a large animal 
model of transplantation tolerance (10), and was postulated 
to explain the significance of numerous donor cells of DC 
morphology found in tissues of humans bearing functional 
allogratts for up to 30 years atter transplantation \l-4) and 
in experimental models of long-surviving organ recipients 
(6-Rl. 
Proving the presence of circulating DCs was a formidable 
undertaking. Cntil the report of Romani et al. (20). there was 
110 way to reliablv propagate DCs from their committed pro-
genitors in humans. Using this new method, we were able to 
acquire from the PBMCs of healthy volunteers, as well as 
from BM-augmented organ allograft recipients, an adequate 
quantity ofleukocytes that had typical characteristics of DCs 
(20,27) with which to undertake further investigations. Cul-
tured DCs, when used as stimulators in primary MLR as-
says, triggered marked proliferation of naive allogeneic T 
cells. Additionally, cultured and sorted (class nbright/lin_ 
eagenull) cells had the distinctive morphologic features char-
acteristic of mature DCs (veils, sparse secretory granules, 
and abundant mitochondrial. With the phenotypic analysis, 
comparable levels of expression ofCDla and B7-2 (CD86) cell 
surface molecules were seen in the cultured/sorted DCs ob-
tained from the peripheral blood of control and study pa-
tients. The expression, however, of B7-1 (CD80) was mark-
edly down-regulated in the BM-augmented recipients as 
compared with that in the controls. The functional signifi-
cance of this finding remains to be clarified. 
Having confirmed that the propagated cells were indeed of 
dendritic leukocyte lineage, the next task was to determine 
their origin (donor vs. recipient). For this purpose, "culture! 
sorted" cells, the purity of which had been confirmed by 
reanalysis, were used. The final step was achieved by dem-
onstrating by PCR within sorted (class nbright/lineagenull) 
DCs, the presence of cells of donor origin. 
Although prima tUcie evidence for engraftment ofhematopoi-
etic precursor and/or stem cells of donor origin was the detection 
of chimerism In successful long-term organ allograft recIpients. 
this paper nevertheless proVIdes strong evidence for the eXlS-
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tence of progenitors of donor Des in the peripheral blood of 
8M-augmented patients. It also establishes unequivocally the 
lJlultilineage nature of donor cell chimerism in human organ 
allograft recipients. We anticipate to utilize the techniques re-
ported herein as appropriate tools to initiate a systematic 
search for the cellular and molecular mechanisms involved in 
the induction of transplantation tolerance, 
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